FIDIS™ Celiac IgA and IgG Panels
The BMD FIDIS™ Celiac Panels utilise the Luminex® xMAP technology to simultaneously detect tissue Transglutaminase (tTG) and Gliadin autoantibodies in a patient sample with only one assay procedure for each isotype.
The FIDIS™ is now in routine use in Australia and New Zealand. The Celiac Panels are demonstrating excellent results as shown in the RCPA QAP Immunology Program for Celiac antibodies. Further data showing the excellent performance of the FIDIS™ Celiac panels can be obtained by contacting Diagnostic Solutions.
- Human recombinant tissue Transglutaminase (tTG) antigen source
- Fully automated using the BMD CARIS™ front-end pipetting system
- Fast turnaround of results
- 30:30 incubation times
- <30 secs per sample reading time using the FIDIS™ Luminex® system
- Bi-directional LIS interface
- enabling only requested tests to be reported
- On-board Levey-Jennings QC monitoring
Other FIDIS™ Panels
BMD have an extensive range of Autoimmune Panels now available using the FIDIS™ system. They include the following;
-
Connective 10 Panel: simultaneous detection and characterisation of dsDNA, Centromere and 8 ENA antibodies.
Learn more
-
Thyroid Panel: simultaneous detection of antibodies to TPO and Thyroglobulin (a-TG).
Learn more
-
Vasculitis Panel: simultaneous detection of antibodies to ANCA-MPO, ANCA-PR3 and GBM.
Learn more
-
Rheuma Panel: simultaneous detection of IgM antibodies to Human and Animal Rheumatoid Factor.
Learn more
-
Cytokine Panels: there are now a large range of human cytokine panels also available using the FIDIS™ System.
Learn More
Coeliac Quality Control (QC)
Diagnostic Solutions has
QC material available for use by ELISA or FIDIS™ methodologies.
Learn more.
Back to TOP